A Novel Analgesic Compound OT-7100 Attenuates Nociceptive Responses in Animal Models of Inflammatory and Neuropathic Hyperalgesia: A Possible Involvement of Adenosinergic Anti-nociception.

  • Yasuda Tsuneo
    Nutrition Research Institute, Otsuka Pharmaceutical Factory, Inc.
  • Okamoto Keiichiro
    Department of Anatomy and Neurobiology, Wakayama Medical University
  • Iwamoto Takeshi
    Nutrition Research Institute, Otsuka Pharmaceutical Factory, Inc.
  • Miki Shinya
    Nutrition Research Institute, Otsuka Pharmaceutical Factory, Inc.
  • Yoshinaga Norihiro
    Nutrition Research Institute, Otsuka Pharmaceutical Factory, Inc.
  • Sato Seiji
    Nutrition Research Institute, Otsuka Pharmaceutical Factory, Inc.
  • Noguchi Koichi
    Department of Anatomy and Neuroscience, Hyogo College of Medicine
  • Senba Emiko
    Department of Anatomy and Neurobiology, Wakayama Medical University

書誌事項

タイトル別名
  • Novel Analgesic Compound OT 7100 Attenuates Nociceptive Responses in Animal Models of Inflammatory and Neuropathic Hyperalgesia A Possible Involvement of Adenosinergic Anti nociception

この論文をさがす

抄録

We studied the effects of OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo [1,5-a]pyrimidine), a novel analgesic compound, on the inhibitory action of adenosine on the contraction of guinea pig ileum and investigated the effects of OT-7100 on the nociceptive responses in animal models of inflammatory and peripheral neuropathic hyperalgesia and decreases spinal c-Fos expression. OT-7100 at 0.3 – 3 μM significantly enhanced the inhibitory effect of adenosine on the contraction of guinea pig ileum. The efficacy of OT-7100 (1, 3 or 10 mg/kg, p.o.) on hyperalgesia induced by yeast or substance P and in the Bennett model was significantly suppressed by coadministration of the adenosine A1 antagonist DPCPX (0.01 or 0.1 pmol/animal, i.t.), while OT-7100 without DPCPX significantly increased the nociceptive threshold in each rat model. OT-7100 (3, 10 and 30 mg/kg per day, p.o.) significantly inhibited the mechanical nociceptive threshold in the injured paw in the Chung model. OT-7100 (30 mg/kg, p.o.) significantly decreased the number of Fos-LI neurons in the spinal dorsal horn in the Bennett model. These finding suggest that OT-7100 inhibits hyperalgesia in these animal models possibly by enhancing adenosinergic neurotransmission in the dorsal horn, although we still lack direct evidence for it.

収録刊行物

  • Jpn.J.Pharmacol.

    Jpn.J.Pharmacol. 87 (3), 214-225, 2001

    公益社団法人 日本薬理学会

参考文献 (63)*注記

もっと見る

詳細情報

問題の指摘

ページトップへ